Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Cancer Pain 2Stomatitis 1Pain 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma 1Hematologic Neoplasms 1Head and Neck Neoplasms 1

Interventions

Gemcitabine 34pembrolizumab 27Paclitaxel 21Cyclophosphamide 21Docetaxel 20Carboplatin 20Irinotecan 19Capecitabine 19Fluorouracil 17Bevacizumab 15Dexamethasone 14fludarabine 13Oxaliplatin 13Leucovorin 13Blood Specimen Collection 13Everolimus 12Cetuximab 12Ipilimumab 11Erlotinib Hydrochloride 11Rituximab 10Pemetrexed 10Cisplatin 10venetoclax 9Temozolomide 9Sunitinib 9Nivolumab 9Trastuzumab 8Interleukin-2 8aldesleukin 7Epoetin Alfa 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Neoplasms × Sodium Bicarbonate × Clear all
NCT01846429 2015-06-04

Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Terminated
9 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Cancer Pain, Lymphoma, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Pain, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡